Depression is a broad, everyday term that covers everything from temporary sadness after a breakup to a severe, lasting mental health condition. Major depressive disorder (MDD) is a specific clinical diagnosis with defined criteria: at least five symptoms persisting for two or more weeks that interfere with daily life. In short, all major depressive disorder is depression, but not all depression is major depressive disorder.
Depression as an Umbrella Term
When most people say “I’m depressed,” they’re describing a mood, not a diagnosis. Feeling sad, unmotivated, or emotionally flat after a job loss, a breakup, or a stressful month is a normal human response. This kind of low mood usually lifts as circumstances change or as you adjust. It can last days or even a few weeks, but it tends to stay connected to the situation that caused it.
Clinicians sometimes call this “situational depression” or an adjustment reaction. It’s real and it can be painful, but it doesn’t meet the threshold for a psychiatric diagnosis. The key distinction: situational low mood is proportional to what triggered it, and it fades. Major depressive disorder is not proportional, often has no clear trigger, and doesn’t simply resolve on its own.
What Makes Major Depressive Disorder Different
Major depressive disorder has a precise definition in the Diagnostic and Statistical Manual of Mental Disorders (DSM-5). To qualify, a person must have at least five of the following nine symptoms, present nearly every day for at least two consecutive weeks:
- Depressed mood for most of the day
- Loss of interest or pleasure in activities you used to enjoy
- Significant changes in appetite or weight (either direction)
- Sleep disruption, either insomnia or sleeping far too much
- Physical restlessness or noticeable slowing down
- Fatigue or loss of energy
- Feelings of worthlessness or excessive guilt
- Difficulty thinking, concentrating, or making decisions
- Recurrent thoughts of death or suicide
At least one of the five symptoms must be either depressed mood or loss of interest. That’s a hard requirement. Someone who has fatigue, poor concentration, sleep problems, and appetite changes but doesn’t feel sad or lose interest in things wouldn’t meet the criteria, even though they’re clearly struggling.
The two-week minimum and the “nearly every day” language are what separate MDD from ordinary sadness. A few bad days don’t qualify. The symptoms need to be persistent, present most of the day, and causing real interference with work, relationships, or basic self-care.
How Severity Is Measured
Clinicians often use a screening tool called the PHQ-9, a nine-question survey that maps directly onto the DSM-5 symptom list. Each item is scored 0 to 3, producing a total between 0 and 27. The score ranges break down like this: 0 to 4 means no significant depression, 5 to 9 is mild, 10 to 14 is moderate, 15 to 19 is moderately severe, and 20 to 27 is severe. A score of 10 or above typically warrants a closer clinical evaluation. You may encounter this questionnaire at a primary care visit, a therapy intake, or even through a mental health app.
MDD vs. Persistent Depressive Disorder
Major depressive disorder isn’t the only formal depressive diagnosis. Persistent depressive disorder (formerly called dysthymia) involves milder symptoms that don’t fully meet MDD criteria but last two years or longer. Think of it as a low-grade depression that becomes the background noise of someone’s life. The cumulative burden can be just as damaging as MDD, even though the day-to-day experience feels less intense.
It’s also possible to have both at once. Some people live with persistent depressive disorder and then experience a full major depressive episode on top of it, sometimes called “double depression.” The DSM-5 merged chronic depression and dysthymia into the persistent depressive disorder category, putting more weight on how long symptoms last rather than just how severe they are.
What Happens in the Brain During MDD
MDD involves measurable changes in brain activity, particularly in the areas that process emotions, regulate stress, and control motivation. The amygdala, which handles threat detection and negative emotions, becomes overactive. Neuroimaging studies show that people with depression have dramatically heightened amygdala responses to sad faces compared to non-depressed people, yet their response to happy faces looks the same as everyone else’s. The brain, in effect, develops a negativity bias at the hardware level.
At the same time, the prefrontal cortex and hippocampus, which normally keep emotional responses in check, become less active. Under chronic stress, the body releases excess stress hormones that can actually damage neurons in the hippocampus and prefrontal cortex. This weakens their ability to calm the amygdala, creating a feedback loop: more stress leads to more amygdala activation, which triggers more stress hormones, which causes more damage to the brain regions that could break the cycle. This is one reason MDD doesn’t just “snap out of it” with willpower. The regulatory system itself is compromised.
Medical Conditions That Mimic Depression
Part of diagnosing MDD involves ruling out physical causes that produce identical symptoms. Thyroid disorders are among the most common culprits. Roughly 45% of people diagnosed with depressive disorders also have autoimmune thyroid inflammation, and an underactive thyroid alone can cause fatigue, weight gain, poor concentration, and depressed mood. Other conditions that can look like depression include sleep apnea, vitamin deficiencies, Lyme disease, Cushing syndrome, and early-stage neurological diseases like Parkinson’s or dementia.
Certain medications can also trigger depressive symptoms: some blood pressure drugs, steroids, hormonal treatments, and even some acid reflux medications. This is why a thorough evaluation for MDD typically includes blood work and a medication review before settling on a diagnosis.
How MDD Is Treated
Treatment for MDD generally follows three phases. The acute phase, lasting six to twelve weeks, focuses on reducing symptoms enough to restore daily functioning. The continuation phase, four to nine months, aims to prevent the symptoms from coming back. A maintenance phase beyond one year may be recommended for people with recurrent episodes.
First-line options include antidepressant medication, psychotherapy, or both. For severe depression, the combination tends to work better than either one alone. Among therapy approaches, cognitive behavioral therapy has the strongest evidence base, though interpersonal therapy, psychodynamic therapy, and behavioral activation also show effectiveness.
Antidepressants typically take several weeks to reach full effect. Most people start with an SSRI or SNRI, two medication classes that work by increasing the availability of chemical messengers involved in mood regulation. If the first medication doesn’t produce meaningful improvement within about eight weeks, switching to a different one or adding a second approach is standard practice. The goal isn’t just feeling “less bad” but reaching remission, the point where symptoms are gone or nearly gone and daily life feels manageable again.
Who Is Most Affected
Globally, about 5.7% of adults experience depression at any given time. Women are roughly 1.5 times more likely than men to be affected: 6.9% of women compared to 4.6% of men. More than 10% of pregnant women and new mothers experience depression, a rate that highlights the role hormonal shifts and life stress play in triggering episodes. Adults over 70 also face elevated risk, with a prevalence of about 5.9%.
These numbers represent diagnosed or identifiable cases. The actual burden is almost certainly higher, since many people with MDD never seek treatment or attribute their symptoms to stress, aging, or personality rather than a treatable condition.